CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP (HCMRP). Hemocentro de Ribeirão Preto (Institutional affiliation from the last research proposal) Birthplace: Brazil
Maria Carolina de Oliveira Rodrigues in research grants and scholarships supported by FAPESP.
| Articles published in Pesquisa para Inovação FAPESP about the researcher: |
| Artificial skin can assist development of treatments for systemic sclerosis |
| More itemsLess items |
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Type 1 Diabetes (T1D) is characterized by the destruction of ² cells in the pancreas, resulting in a deficiency in the production of insulin. The conventional treatment for T1D involves exogenous insulin replacement, a process that affects the patient's quality of life and does not fully prevent the development of chronic complications of the disease. In this scenario, the Hematopoietic S…
Systemic sclerosis (SSc) is an autoimmune disease marked by fibrosis of the skin and internal organs, immune dysregulation and vasculopathy. Autologous hematopoietic stem cell transplantation (AHSCT) has been investigated as treatment for patients with severe and progressive SSc. Although patients show great clinical and histopathological improvement of cutaneous fibrosis after transplant…
Systemic sclerosis is an autoimmune disease characterized by microvasculopathy, immune dysregulation and excessive production of collagen, resulting fibrosis of the skin and internal organs. The etiology of SSc remains unknown, and treatment is organ-directed, based on the extent and severity of lesions. The efficacy of conventional therapeutic strategies for SSc is limited, especially in…
Systemic Sclerosis (SSc) is a rheumatic disease that causes progressive fibrosis of the skin and may affect internal organs. It presents high morbidity and mortality, and in severe cases, where cutaneous involvement is diffuse or in which there is involvement of the lungs, heart or kidneys, mortality may reach 30 to 50% in five years, even under conventional immunosuppressive treatment. A…
Systemic sclerosis (SSc) is a rheumatic disease that causes progressive fibrosis of the skin and may affect internal organs. It presents high morbidity and mortality, and in severe cases, where cutaneous involvement is diffuse or in which there is involvement of the lungs, heart or kidneys, mortality may reach 30 to 50% in five years, even under conventional immunosuppressive treatment. A…
(Only some records are available in English at this moment)
Systemic sclerosis (SSc) is an autoimmune disease marked by fibrosis of the skin and internal organs, immune dysregulation, and vasculopathy. The skin fibrosis in SSc results from the activation of the resident fibroblasts by immune cells. SSc fibroblasts synthesize, in an aberrant manner, many extracellular matrix molecules (ECM), contributing to skin thickening and stiffening. Thus, we …
The present study will be conducted in the University of South Florida Department of Neurosurgery. This is an important center of research for amyotrophic lateral sclerosis (ALS), under the leadership of Dr. Garbuzova-Davis. In this center are developed experimental studies with the ALS mouse transgenic model (G93A-SOD1 mutation), besides studies with human tissue from ALS patients. The p…
| 1 / 0 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 4 / 4 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 10 / 9 | All research grants and scholarships |
| Associated processes | |